2 completed, 1 unknown. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Stupor: new trials by email Literature Review of Stupor trials Research Report on Stupor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of De-stress and Focus Capsule in the Management of Stress. De-Stress and Focus capsule- U001, De-Stress and Focus capsule - I001, Placebo capsules 001 - Anxiety, Stress | Not applicable | Unknown | Herbolab India Pvt. Ltd. | 60 | 2024-09-05 | 2024-08-26 |
| Hypercapnia: Cognitive Effects and Monitoring NO exercise at depth, exercise at depth - Hypercapnia, Exercise | Not applicable | Completed | Duke University | 58 | 2013-01-01 | 2016-05-25 |
| Lethargic Depression Study Extended-release bupropion (HCl) - Epilepsy, Major Depressive Disorder (MDD) | Phase 3 | Completed | GlaxoSmithKline | 268 | 2003-06-01 | 2017-05-30 |
Anxiety Disorders (1) · Cognitive Dysfunction (1) · Depression (1) · Depressive Disorder, Major (1) · Epilepsy (1) · Fatigue (1) · Hypercapnia (1) · Inert Gas Narcosis (1) · Motor Activity (1)
Consciousness Disorders (3) · Mental Disorders (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Unconsciousness (3) · Behavior (2) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Cognition Disorders (1) · Depressive Disorder (1)
Duke University (1) · GlaxoSmithKline (1) · Herbolab India Pvt. Ltd. (1)
United States (2)
Dr. Ramshyam Agarwal, MBBS, DNB (1) · John J Freiberger, MD (1)